Outlook Therapeutics, Inc. (OTLK) Tops Q1 EPS by 1c

Outlook Therapeutics, Inc. (NASDAQ: OTLK) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Outlook Therapeutics, Inc. (OTLK) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)